Humanitas Research Hospital at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

Humanitas Research Hospital brings 2 presentations to ISLB 2026 in Madrid. Its work centres on multi-layer liquid biopsy for finding minimal residual disease and early relapse in ovarian cancer. One study, the IOLANTHE trial, profiles cell-free DNA in several ways to track treatment response in advanced epithelial ovarian cancer.

OrganizationISLB 2026 Attendance
humanitas.it
Hospitals & cancer centres
Private research and teaching hospital near Milan.
Talk
Sun Nov 8
9:30am–11:00am
Poster
Part of Poster sessions
Multi-layer cfDNA Profiling for Monitoring Treatment Response and Detecting MRD in advanced Epithelial Ovarian Cancer: Preliminary Results from IOLANTHE Trial
ctDNA & MRD · Clinical use
Collaborators: Humanitas University, Sapienza University of Rome

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Humanitas Research Hospital

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction